Your browser doesn't support javascript.
loading
Safety and Immune Responses Following Anti-PD-1 Monoclonal Antibody Infusions in Healthy Persons With Human Immunodeficiency Virus on Antiretroviral Therapy.
Gay, Cynthia L; Bosch, Ronald J; McKhann, Ashley; Cha, Raymond; Morse, Gene D; Wimbish, Chanelle L; Campbell, Danielle M; Moseley, Kendall F; Hendrickx, Steven; Messer, Michael; Benson, Constance A; Overton, Edgar T; Paccaly, Anne; Jankovic, Vladimir; Miller, Elizabeth; Tressler, Randall; Li, Jonathan Z; Kuritzkes, Daniel R; Macatangay, Bernard J C; Eron, Joseph J; Hardy, W David.
Afiliación
  • Gay CL; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Bosch RJ; Department of Biostatistics, Center for Biostatistics and AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
  • McKhann A; Department of Biostatistics, Center for Biostatistics and AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Cha R; Center for Integrated Global Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.
  • Morse GD; Center for Integrated Global Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.
  • Wimbish CL; Department of Clinical Research, Social and Scientific Systems, Inc, a DLH Company, Silver Spring, Maryland, USA.
  • Campbell DM; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
  • Moseley KF; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Hendrickx S; Department of Medicine, University of California, San Diego, San Diego, California, USA.
  • Messer M; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Benson CA; Department of Medicine, University of California, San Diego, San Diego, California, USA.
  • Overton ET; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Paccaly A; North America Medical Affairs, ViiV Healthcare, Durham, North Carolina, USA.
  • Jankovic V; Departments of Clinical Sciences, Translational Medicine and Precision Medicine, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
  • Miller E; Departments of Clinical Sciences, Translational Medicine and Precision Medicine, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
  • Tressler R; Departments of Clinical Sciences, Translational Medicine and Precision Medicine, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
  • Li JZ; HIV Research Branch, Division of AIDS, National Institute of AIDS, National Institutes of Health, Rockville, Maryland, USA.
  • Kuritzkes DR; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Macatangay BJC; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Eron JJ; Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Hardy WD; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Open Forum Infect Dis ; 11(3): ofad694, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38449916
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos